Perhaps because it was because the company already had a significant drug in the market with some sales history and growth prospects, that the company was already fairly valued?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.84 |
Change
-0.120(0.93%) |
Mkt cap ! $1.609B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.70 | $2.921M | 226.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 4752 | $12.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.84 | 710 | 12 |
View Market Depth
| Last trade - 14.25pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |